Concepedia

Author

Minerva Batugo

Pfizer (United States)

Also Known As

M. Batugo, Minerva Batugo, Minerva R. Batugo

12

Publications

521

Citations

8

H-Index

15

Concepts

All Affiliations

Pfizer (United States)Tethys Research Institute
MB

About

Minerva Batugo is an author at Pfizer (United States) specializing in medicine, pharmacology, and glaucoma.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

145

2

Pharmacology

2

2

145

3

Natural Sciences

1

1

113

4

Biochemistry

1

1

113

5

Drug Discovery

1

1

113

Minerva Batugo

×

7

Publications

509

Citations

7

H-Index

YearCitations

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 6. Structure−Activity Studies of Orally Bioavailable, 2-Pyridone-Containing Peptidomimetics

Peter S. Dragovich, Thomas J. Prins, Ru Zhou,

Journal of Medicinal Chemistry

2002

140

Structure-Based Design, Synthesis, and Biological Evaluation of Irreversible Human Rhinovirus 3C Protease Inhibitors. 8. Pharmacological Optimization of Orally Bioavailable 2-Pyridone-Containing Peptidomimetics

Peter S. Dragovich, Thomas J. Prins, Ru Zhou,

Journal of Medicinal Chemistry

2003

113

Characterization of Human Corneal Epithelial Cell Model As a Surrogate for Corneal Permeability Assessment: Metabolism and Transport

Cathie Xiang, Minerva Batugo, David C. Gale,

Drug Metabolism and Disposition

2009

70

A Novel Nitric Oxide Releasing Prostaglandin Analog, NCX 125, Reduces Intraocular Pressure in Rabbit, Dog, and Primate Models of Glaucoma

Valentina Borghi, Elena Bastia, Massimiliano Guzzetta,

Journal of Ocular Pharmacology and Therapeutics

2010

69

Discovery Pharmacokinetic Studies in Mice Using Serial Microsampling, Dried Blood Spots And Microbore Lc–MS/MS

Sadayappan V. Rahavendran, Sylvia Vekich, Heather Skor,

Bioanalysis

2012

48

Intraocular Pressure–Lowering Activity of NCX 470, a Novel Nitric Oxide–Donating Bimatoprost in Preclinical Models

Francesco Impagnatiello, Carol B. Toris, Minerva Batugo,

Investigative Ophthalmology & Visual Science

2015

37

A dual acting compound with latanoprost amide and nitric oxide releasing properties, shows ocular hypotensive effects in rabbits and dogs

Francesco Impagnatiello, Vando Borghi, David C. Gale,

Experimental Eye Research

2011

32

Page 1